mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
MLN4924 |
GDSC1000 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
0.029 |
0.5 |